|
|
Previous Article | Table of Contents | Next Article 
Multiple genetic lesions in acquired immunodeficiency syndrome-related
non-Hodgkin's lymphoma
P Ballerini, G Gaidano, JZ Gong, V Tassi, G Saglio, DM Knowles and R Dalla-Favera
Department of Pathology, College of Physicians & Surgeons, Columbia
University, New York, NY 10032.
Non-Hodgkin's lymphoma (NHL) develops in about 5% to 10% of acquired
immunodeficiency syndrome (AIDS) patients. The vast majority of AIDS- NHL
are clinically aggressive B-cell NHL that are histologically classified as
small noncleaved cell lymphoma (SNCCL), large cell immunoblastic
plasmacytoid lymphoma (LC-IBPL), and large noncleaved cell lymphoma
(LNCCL). In an attempt to understand the molecular pathogenesis of these
tumors, we have investigated the involvement of dominantly acting oncogenes
(c-myc, N-, K-, H-Ras), tumor suppressor genes (p53, RB1), and Epstein-Barr
virus (EBV) infection in 27 AIDS-NHL samples (16 SNCCL, 5 LC-IBP, and 6
LNCCL). The following lesions were detected in AIDS-NHL: EBV infection
(10/24; 41.6%), c-myc rearrangement (19/24; 79.1%), Ras mutation (4/27;
14.8%), and p53 loss/mutation (10/27; 37.0%). These lesions are not
uniformly distributed, but, rather, cluster with specific types of
AIDS-NHL: EBV infection is preferentially associated with LC-IBPL (4/4;
100%), while it is present in only a fraction of SNCCL (5/16; 31.2%) and
LNCCL (1/4; 25%); c-myc oncogene activation clusters with SNCCL (16/16;
100%), whereas it is less frequent in LC-IBPL (1/4; 25%) and LNCCL (2/4;
50%); p53 inactivation is restricted to SNCCL (10/16; 62.5%) and
consistently associated with c-myc activation. These data show that
AIDS-NHL are associated with multiple genetic lesions that involve both
proto- oncogenes and tumor suppressor genes and may accumulate in the
relatively short period of time (4 to 6 years) between human
immunodeficiency virus infection and AIDS-NHL development. These genetic
lesions differ in the various AIDS-NHL subtypes, suggesting the involvement
of distinct molecular pathway.
Volume 81,
Issue 1,
pp. 166-176,
01/01/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. K. Marr-Belvin, A. K. Carville, M. A. Fahey, K. Boisvert, S. A. Klumpp, M. Ohashi, F. Wang, S. P. O'Neil, and S. V. Westmoreland
Rhesus Lymphocryptovirus Type 1-associated B-cell Nasal Lymphoma in SIV-infected Rhesus Macaques
Vet. Pathol.,
November 1, 2008;
45(6):
914 - 921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Paulsen, M. M. Rosenkilde, J. Eugen-Olsen, and T. N. Kledal
Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor
J. Virol.,
January 1, 2005;
79(1):
536 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rivailler, A. Carville, A. Kaur, P. Rao, C. Quink, J. L. Kutok, S. Westmoreland, S. Klumpp, M. Simon, J. C. Aster, et al.
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host
Blood,
September 1, 2004;
104(5):
1482 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Sisk, C. R. Bradford, T. E. Carey, A. Paulino, and E. Robertson
Epstein-Barr Virus Detected in a Head and Neck Squamous Cell Carcinoma Cell Line Derived From an Immunocompromised Patient
Arch Otolaryngol Head Neck Surg,
October 1, 2003;
129(10):
1115 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gaidano, L. Pasqualucci, D. Capello, E. Berra, C. Deambrogi, D. Rossi, L. Maria Larocca, A. Gloghini, A. Carbone, and R. Dalla-Favera
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma
Blood,
September 1, 2003;
102(5):
1833 - 1841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Alain, K. Hirasawa, K. J. Pon, S. G. Nishikawa, S. J. Urbanski, Y. Auer, J. Luider, A. Martin, R. N. Johnston, A. Janowska-Wieczorek, et al.
Reovirus therapy of lymphoid malignancies
Blood,
December 1, 2002;
100(12):
4146 - 4153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fournel-Fleury, F. Ponce, P. Felman, A. Blavier, C. Bonnefont, L. Chabanne, T. Marchal, J. L. Cadore, I. Goy-Thollot, D. Ledieu, et al.
Canine T-cell Lymphomas: A Morphological, Immunological, and Clinical Study of 46 New Cases
Vet. Pathol.,
January 1, 2002;
39(1):
92 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Zhu, R. S Levine, E. A Brann, Y. Gu, L. S Caplan, I. Hall, and M. K Baum
Risk factors for non-Hodgkin's lymphoma according to family history of haematolymphoproliferative malignancies
Int. J. Epidemiol.,
August 1, 2001;
30(4):
818 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sei, D. P. O'Neill, S. K. Stewart, Q.-e. Yang, M. Kumagai, A. M. Boler, M. A. Adde, S. L. Zwerski, L. V. Wood, D. J. Venzon, et al.
Increased Level of Stromal Cell-Derived Factor-1 mRNA in Peripheral Blood Mononuclear Cells from Children with AIDS-related Lymphoma
Cancer Res.,
July 1, 2001;
61(13):
5028 - 5037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Schroeder, A. J. Saah, D. R. Hoover, J. B. Margolick, R. F. Ambinder, O. Martinez-Maza, E. C. Breen, L. P. Jacobson, D. Variakojis, D. T. Rowe, et al.
Serum Soluble CD23 Level Correlates with Subsequent Development of AIDS-related Non-Hodgkin's Lymphoma
Cancer Epidemiol. Biomarkers Prev.,
November 1, 1999;
8(11):
979 - 984.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. G.S. Chirivi, G. Taraboletti, M. R. Bani, L. Barra, G. Piccinini, M. Giacca, F. Bussolino, and R. Giavazzi
Human Immunodeficiency Virus-1 (HIV-1)-Tat Protein Promotes Migration of Acquired Immunodeficiency Syndrome-Related Lymphoma Cells and Enhances Their Adhesion to Endothelial Cells
Blood,
September 1, 1999;
94(5):
1747 - 1754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Teitell, M. A. Damore, G. G. Sulur, D. E. Turner, M.-H. Stern, J. W. Said, C. T. Denny, and R. Wall
TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues
PNAS,
August 17, 1999;
96(17):
9809 - 9814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Z. Gong, S. Zheng, R. Chiarle, C. De Wolf-Peeters, G. Palestro, G. Frizzera, and G. Inghirami
Detection of Immunoglobulin {kappa} Light Chain Rearrangements by Polymerase Chain Reaction : An Improved Method for Detecting Clonal B-CellLymphoproliferative Disorders
Am. J. Pathol.,
August 1, 1999;
155(2):
355 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Rabkin, Q.-e. Yang, J. J. Goedert, G. Nguyen, H. Mitsuya, and S. Sei
Chemokine and Chemokine Receptor Gene Variants and Risk of Non-Hodgkin's Lymphoma in Human Immunodeficiency Virus-1-Infected Individuals
Blood,
March 15, 1999;
93(6):
1838 - 1842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Larocca, D. Capello, A. Rinelli, S. Nori, A. Antinori, A. Gloghini, A. Cingolani, A. Migliazza, G. Saglio, S. Cammilleri-Broet, et al.
The Molecular and Phenotypic Profile of Primary Central Nervous System Lymphoma Identifies Distinct Categories of the Disease and Is Consistent With Histogenetic Derivation From Germinal Center-Related B Cells
Blood,
August 1, 1998;
92(3):
1011 - 1019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Maggiorella, F. Monardo, M. L. Koanga-Mogtomo, L. Cioe, L. Sernicola, F. Corrias, C. D. Baroni, P. Verani, and F. Titti
Detection of Infectious Simian Immunodeficiency Virus in B- and T-Cell Lymphomas of Experimentally Infected Macaques
Blood,
May 1, 1998;
91(9):
3103 - 3111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gaidano, A. Carbone, and R. Dalla-Favera
Genetic Basis of Acquired Immunodeficiency Syndrome-Related Lymphomagenesis
J Natl Cancer Inst Monographs,
April 1, 1998;
1998(23):
95 - 100.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Moses, J. Nelson, and G. C. Bagby Jr
The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis
Blood,
March 1, 1998;
91(5):
1479 - 1495.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carbone, G. Gaidano, A. Gloghini, L. M. Larocca, D. Capello, V. Canzonieri, A. Antinori, U. Tirelli, B. Falini, and R. Dalla-Favera
Differential Expression of BCL-6, CD138/Syndecan-1, and Epstein-Barr Virus-Encoded Latent Membrane Protein-1 Identifies Distinct Histogenetic Subsets of Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphomas
Blood,
February 1, 1998;
91(3):
747 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gaidano, A. Carbone, C. Pastore, D. Capello, A. Migliazza, A. Gloghini, S. Roncella, M. Ferrarini, G. Saglio, and R. Dalla-Favera
Frequent Mutation of the 5' Noncoding Region of the BCL-6 Gene in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphomas
Blood,
May 15, 1997;
89(10):
3755 - 3762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cesarman, Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles
Kaposi's Sarcoma-Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity-Based Lymphomas
N. Engl. J. Med.,
May 4, 1995;
332(18):
1186 - 1191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Lynch and N. L. Harris
Case 27-1994- A 41-Year-Old Woman with Neurologic Abnormalities and an Osteolytic Lesion in the Mandible
N. Engl. J. Med.,
July 14, 1994;
331(2):
107 - 113.
[Full Text]
|
 |
|
|
|